Dwayne Stupack

9PUBLICATIONS
36CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 26, 2025
Ovarian Tumor FAK Inhibition Releases Omega-3 Fatty Acids Stimulating GATA6 Peritoneal Macrophage CXCL13 Production Enhancing Immunotherapy.

Xiao Lei Chen, Kevin M Tharp, Marjaana Ojalill

|Sep 13, 2025
Liposomal Doxorubicin, but Not Platinum-Taxane, Supports MHC-II Expression and Immune Maturation in the Ovarian Tumor Microenvironment.

Hyojae Lee, Xiao-Lei Chen, Duygu Ozmadenci

|Dec 04, 2024
Durable antitumor response via an oncolytic virus encoding decoy-resistant IL-18.

Yan Cheng, Yuanhui Zhao, Yu Liu

|Nov 25, 2024
Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma.

Yichi Zhang, Marjaana Ojalill, Antonia Boyer

|Nov 22, 2024
Inducible FAK Deletion but not FAK Inhibition in Endothelial Cells Activates p53 to Suppress Tumor Growth in PYK2-null Mice.

Xiao Lei Chen, Marjaana Ojalill, Christine Jean

|Jul 22, 2024
Focal adhesion kinase signaling - tumor vulnerabilities and clinical opportunities.

David D Schlaepfer, Marjaana Ojalill, Dwayne G Stupack

Pageof 2

Frequent Collaborators

7 joint publications

David D Schlaepfer

5 joint publications

Marjaana Ojalill

5 joint publications

Xiao-Lei Chen

3 joint publications

Duygu Ozmadenci